Karen Soares Sells 52,500 Shares of Clover Health Investments, Corp. (NASDAQ:CLOV) Stock

Clover Health Investments, Corp. (NASDAQ:CLOVGet Free Report) General Counsel Karen Soares sold 52,500 shares of the firm’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $3.80, for a total value of $199,500.00. Following the completion of the transaction, the general counsel now owns 1,299,663 shares in the company, valued at approximately $4,938,719.40. This trade represents a 3.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Clover Health Investments Stock Performance

NASDAQ CLOV opened at $3.64 on Friday. The business’s fifty day moving average is $4.08 and its 200 day moving average is $3.62. The company has a market capitalization of $1.82 billion, a PE ratio of -18.20 and a beta of 2.00. Clover Health Investments, Corp. has a fifty-two week low of $0.61 and a fifty-two week high of $4.87.

Analyst Ratings Changes

Several equities analysts recently weighed in on CLOV shares. Canaccord Genuity Group lifted their target price on Clover Health Investments from $4.20 to $4.50 and gave the company a “buy” rating in a research report on Monday, March 3rd. Craig Hallum started coverage on Clover Health Investments in a research report on Tuesday, December 17th. They set a “buy” rating and a $6.00 target price on the stock.

Check Out Our Latest Report on Clover Health Investments

Institutional Investors Weigh In On Clover Health Investments

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. raised its holdings in Clover Health Investments by 2.0% during the fourth quarter. Vanguard Group Inc. now owns 19,585,213 shares of the company’s stock valued at $61,693,000 after acquiring an additional 386,499 shares during the period. Geode Capital Management LLC raised its holdings in Clover Health Investments by 1.1% during the fourth quarter. Geode Capital Management LLC now owns 4,882,461 shares of the company’s stock valued at $15,387,000 after acquiring an additional 53,760 shares during the period. Marshall Wace LLP raised its holdings in Clover Health Investments by 167.6% during the fourth quarter. Marshall Wace LLP now owns 3,769,765 shares of the company’s stock valued at $11,875,000 after acquiring an additional 2,360,902 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in Clover Health Investments by 5.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 3,000,505 shares of the company’s stock valued at $8,461,000 after acquiring an additional 150,550 shares during the period. Finally, State Street Corp raised its holdings in Clover Health Investments by 65.0% during the third quarter. State Street Corp now owns 2,189,380 shares of the company’s stock valued at $6,174,000 after acquiring an additional 862,621 shares during the period. 19.77% of the stock is owned by institutional investors.

About Clover Health Investments

(Get Free Report)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.

Further Reading

Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.